Literature DB >> 15340705

[Progressive symmetric erythrokeratodermia of Darier-Gottron].

H Ott1, S Lehmann, P Poblete-Gutiérrez, J Frank.   

Abstract

A 5 1/2-year-old boy revealed symmetric erythematous plaques on both arms and legs as well as in the face. Additionally, contractions of several digital joints were noted. We diagnosed a progressive symmetric erythrokeratoderma and initiated a topical therapy with tretinoin. Here we discuss the etiology, differential diagnoses, and therapeutic options of this rare disorder of keratinization.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15340705     DOI： 10.1007/s00105-004-0790-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  13 in total

1.  Towards a better classification of erythrokeratodermias.

Authors:  D Hohl
Journal:  Br J Dermatol       Date:  2000-12       Impact factor: 9.302

2.  Does progressive symmetric erythrokeratoderma exist?

Authors:  M van Steensel
Journal:  Br J Dermatol       Date:  2004-05       Impact factor: 9.302

3.  The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope.

Authors:  A Ishida-Yamamoto; J A McGrath; H Lam; H Iizuka; R A Friedman; A M Christiano
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome.

Authors:  E Maestrini; A P Monaco; J A McGrath; A Ishida-Yamamoto; C Camisa; A Hovnanian; D E Weeks; M Lathrop; J Uitto; A M Christiano
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

5.  Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families.

Authors:  Emmanuelle Bitoun; Stéphane Chavanas; Alan D Irvine; Lorne Lonie; Christine Bodemer; Mauro Paradisi; Dominique Hamel-Teillac; Shin-ichi Ansai; Yoshihiko Mitsuhashi; Alain Taïeb; Yves de Prost; Giovanna Zambruno; John I Harper; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2002-02       Impact factor: 8.551

6.  Erythrokeratodermia with ataxia.

Authors:  J M Giroux; A Barbeau
Journal:  Arch Dermatol       Date:  1972-08

Review 7.  Acitretin in the treatment of erythrokeratodermia variabilis.

Authors:  P C van de Kerkhof; P M Steijlen; R J van Dooren-Greebe; R Happle
Journal:  Dermatologica       Date:  1990

8.  Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.

Authors:  Gabriele Richard; Nkecha Brown; Fatima Rouan; Jan-Gerrit Van der Schroeff; Emilia Bijlsma; Lawrence F Eichenfield; Virginia P Sybert; Kenneth E Greer; Peter Hogan; Carmen Campanelli; John G Compton; Sherri J Bale; John J DiGiovanna; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2003-04       Impact factor: 8.551

9.  Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.

Authors:  G Richard; L E Smith; R A Bailey; P Itin; D Hohl; E H Epstein; J J DiGiovanna; J G Compton; S J Bale
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

10.  Progressive partially symmetric erythrokeratodermia with deafness: histological and ultrastructural evidence for a subtype distinct from Schnyder's syndrome.

Authors:  F Kiesewetter; M Simon; M Fartasch; M Gevatter
Journal:  Dermatology       Date:  1993       Impact factor: 5.366
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.